Hemogenyx Pharmaceuticals (HEMO)

Company name:Hemogenyx Pharmaceuticals Plc
EPIC:HEMOTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BYX3WZ24
Market Segment:SSQ3Share Type:DE
WWW Address:http://www.hemogenyx.com/Description:ORD GBP0.01
 Price Price Change [%] Bid Offer Open High Low Volume
 1.85 images.advfn.com/imagesnew/2/gb/up 0.025 [1.37] 1.80 1.90 1.83 1.85 1.82 2,742,105
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 10.11 546.42 -0.00 - - - - 15.38 - 1.63

Hemogenyx Pharmaceuticals Key Figures

(at previous day's close)
Market Cap.10.11m
Shares In Issue546.42m
Prev. Close1.83
PE Ratio- 
Dividend Yield-%
EPS - basic-p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.17p
Return On Equity (ROE)-%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt0.68m
Gross Gearing133.24%
Quick Assets0.42m
Net Working Capital0.28m
Intangibles / Fixed Assets74.99%
Turnover PS-p
Pre-Tax Profit PS-0.21p
Retained Profit PS-0.20p
Cash PS0.07p
Net Cash PS0.04p
Net Tangible Asset Value PS *-0.10p
Net Asset Value PS-0.05p
Spread0.10 (5.26%) 

Hemogenyx Pharmaceuticals Balance Sheet


Share Price Performance

Sample Period HighLow
1 week1.931.78
4 weeks2.231.73
12 weeks2.681.63
1 year15.381.63

Share Price Chart (5 years)

Hemogenyx Pharmaceuticals Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1.780.084.231.7812.031.84
4 weeks2.13-0.28-12.941.7313.141.90
12 weeks2.33-0.48-20.431.6336.932.01
26 weeks7.30-5.45-74.661.6322.882.55
1 year7.90-6.05-76.581.6313.753.84
3 years2.70-0.85-31.481.057.184.74
5 years3.63-1.78-48.971.056.084.68

Hemogenyx Pharmaceuticals Key Management Ratios

Hemogenyx Pharmaceuticals Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 6.04 
Tobin's Q Ratio (excl. intangibles)7.47 
Dividend Yield-%
Market-to-Book Ratio-38.69 
Price-to-Pre-Tax Profit PS-9.01 
Price-to-Retained Profit PS-9.24 
Price-to-Cash Flow PS-11.17 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS-18.61 
Price-to-Cash PS26.88 
Net Working Capital PS0.05 
Price Pct to Working Capital PS35.95%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Hemogenyx Pharmaceuticals Financial Ratios

(Leverage Ratios)
Debt Ratio140.20%
Debt-to-Equity Ratio-3.49 
Debt-to-Equity Ratio (excl. Intgbl)-1.69 
Debt-to-Equity Market Value0.09 
Net Gearing85.75%
Net Gearing (excl. Intangibles)132.70%
Gross Gearing133.24%
Gross Gearing (excl. Intangibles)206.21%
Gearing Under 1 Year17.29%
Gearing Under 1 Year (excl. Intgbl)26.76%
(Liquidity Ratios)
Net Working Capital to Total Assets35.52%
Current Ratio3.05 
Quick Ratio (Acid Test)3.05 
Liquidity Ratio2.75 
Cash & Equiv/Current Assets89.94%
(Solvency Ratios)
Enterprise Value10.65m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.10 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.94 
Total Debt1.05m
Total Debt/Net Current Assets3.75%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)

Hemogenyx Pharmaceuticals Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-171.38%
Return On Assets (ROA)-65.31%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-%
Return On Investment (ROI)-72.91%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Hemogenyx Pharmaceuticals Dividends

Sorry No Data Available

Hemogenyx Pharmaceuticals Fundamentals

 31 Dec 2017 (USD)31 Dec 2018 (USD)31 Dec 2019 (USD)
pre tax profit-2.36--1.52--1.49-m
attributable profit-2.36--1.48--1.45-m
retained profit-2.36--1.48--1.45-m
eps - basic-1.00 - - 
eps - diluted-1.00 - - 
dividends per share- - - 

Hemogenyx Pharmaceuticals Balance Sheet

 31 Dec 2017 (USD)31 Dec 2018 (USD)31 Dec 2019 (USD)
 31 Dec 2017 (USD)31 Dec 2018 (USD)31 Dec 2019 (USD)
fixed assets fixed assets0.198.00%0.177.56%0.1211.80%m
intangibles intangibles0.2610.75%0.2711.86%0.3735.38%m
fixed investments fixed investments--%--%--%m
current assets - other current assets - other--%--%--%m
stocks stocks--%--%--%m
debtors debtors0.072.91%0.093.93%0.065.32%m
cash & securities cash & securities1.8878.34%1.7676.64%0.5047.50%m
creditors - short creditors - short0.2611.01%0.177.29%0.1817.29%m
creditors - long creditors - long--%1.1751.00%1.22115.95%m
creditors - other creditors - other--%--%--%m
subordinated loans subordinated loans--%--%--%m
insurance funds insurance funds--%--%--%m
ord cap, reserves ord cap, reserves2.1388.99%0.9641.71%-0.35-33.00%m
prefs, minorities prefs, minorities--%--%-0.00-0.24%m
NAV Basic- - - 
NAV Diluted- - - 

Hemogenyx Pharmaceuticals Cash Flow Statement

31 Dec 2017 (USD)31 Dec 2018 (USD)31 Dec 2019 (USD)
Operating CF-0.45-1.35-1.20m
Pre-Financing CF0.58-1.35-1.24m
Retained CF1.80-0.02-1.24m

Hemogenyx Pharmaceuticals Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Hemogenyx ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 10:11:13